Skip to main content
. Author manuscript; available in PMC: 2022 Dec 1.
Published in final edited form as: Curr Opin Chem Biol. 2021 Jul 16;65:74–84. doi: 10.1016/j.cbpa.2021.06.001

Table 1.

Examples of computationally derived molecules from drug repurposing for SARS-CoV-2.

Structure Drug Method In vitro/ in vivo activity Reference
graphic file with name nihms-1716900-t0002.jpg Baricitinib knowledge graph Significantly reduced viral load in human liver spheroids at 400 and 800 nM [1316]
graphic file with name nihms-1716900-t0003.jpg Clemastine Protein interaction map pIC50 5.67 [23]
graphic file with name nihms-1716900-t0004.jpg Cloperastine Protein interaction map pIC50 5.27 [23]
graphic file with name nihms-1716900-t0005.jpg Amodiaquine Ligand-based virtual screen EC50 0.13 μM and 5.4 μM [27]
graphic file with name nihms-1716900-t0006.jpg Zuclopenthixol Ligand-based virtual screen 1.35 μM and 15 μM [27]
graphic file with name nihms-1716900-t0007.jpg Nebivolol Ligand-based virtual screen 2.72 μM and 2.8 μM [27]
graphic file with name nihms-1716900-t0008.jpg Dipyridamole Docking in Mpro IC50 0.53 μM, EC50~0.1 μM [28]